Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Torres-Esquius S
  • Beas F
  • Chen-Liang TH
  • Pomares H
  • Varela ND
  • Hernandez F
  • Xicoy B
  • Hermosín L
  • Arnan M
  • Tazón-Vega B
  • Blanco A
  • Diez-Campelo M
  • Lozano ML
  • Valcárcel D
  • Bosch F
  • Montoro MJ
  • Jerez A
  • GESMD centres

Grupos

Abstract

Patients aged 50 or above diagnosed with myeloid neoplasms (MNs) are typically not candidates for germline testing. However, approximately 8% carry pathogenic germline variants. Allogeneic haematopoietic stem cell transplantation (alloHSCT) remains an option for those aged over 50; neglecting germline testing could mask the risk for relative donor cell-derived MN. We propose a germline-augmented somatic panel (GASP), combining MN predisposition genes with a myeloid somatic panel for timely germline variant identification when initial testing is not indicated. Out of our 133 whole-exome-sequenced MN cases aged over 50 years, 9% had pathogenic/likely variants. GASP detected 92%, compared to 50% with somatic-only panel. Our study highlights the relevance of germline screening in MN, particularly for alloHSCT candidates without established germline-testing recommendations.

© 2024 British Society for Haematology and John Wiley & Sons Ltd.

Datos de la publicación

ISSN/ISSNe:
0007-1048, 1365-2141

BRITISH JOURNAL OF HAEMATOLOGY  WILEY

Tipo:
Article
Páginas:
503-509
PubMed:
38639421
Factor de Impacto:
1,677 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 2

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • HSC transplantation; genetic testing; germline predisposition; myeloid neoplasms

Campos de Estudio

Cita

Compartir